- Home
- ACHV vs ORGN Comparison
ACHV vs ORGN Comparison
Compare ACHV & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- ORGN
- Stock Information
- Founded
- ACHV N/A
- ORGN 2008
- Country
- ACHV United States
- ORGN United States
- Employees
- ACHV N/A
- ORGN N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ORGN Major Chemicals
- Sector
- ACHV Health Care
- ORGN Industrials
- Exchange
- ACHV Nasdaq
- ORGN Nasdaq
- Market Cap
- ACHV 72.5M
- ORGN 72.7M
- IPO Year
- ACHV N/A
- ORGN N/A
- Fundamental
- Price
- ACHV $2.26
- ORGN $0.54
- Analyst Decision
- ACHV Strong Buy
- ORGN Strong Buy
- Analyst Count
- ACHV 3
- ORGN 1
- Target Price
- ACHV $14.33
- ORGN $3.00
- AVG Volume (30 Days)
- ACHV 1.2M
- ORGN 796.8K
- Earning Date
- ACHV 08-12-2025
- ORGN 08-13-2025
- Dividend Yield
- ACHV N/A
- ORGN N/A
- EPS Growth
- ACHV N/A
- ORGN N/A
- EPS
- ACHV N/A
- ORGN N/A
- Revenue
- ACHV N/A
- ORGN $29,887,000.00
- Revenue This Year
- ACHV N/A
- ORGN $49.18
- Revenue Next Year
- ACHV N/A
- ORGN $144.81
- P/E Ratio
- ACHV N/A
- ORGN N/A
- Revenue Growth
- ACHV N/A
- ORGN N/A
- 52 Week Low
- ACHV $1.84
- ORGN $0.40
- 52 Week High
- ACHV $5.31
- ORGN $1.90
- Technical
- Relative Strength Index (RSI)
- ACHV 35.12
- ORGN 60.10
- Support Level
- ACHV $2.00
- ORGN $0.42
- Resistance Level
- ACHV $3.90
- ORGN $0.50
- Average True Range (ATR)
- ACHV 0.28
- ORGN 0.03
- MACD
- ACHV -0.18
- ORGN 0.02
- Stochastic Oscillator
- ACHV 13.68
- ORGN 84.22
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.